January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read MorePosted by Chaunie Brusie | Apr 14, 2019 | Breast, Cardiovascular, Culture Media, Lymphoma, Melanoma, Prostate, Slides |
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read MorePosted by Chaunie Brusie | Apr 13, 2019 | Research |
The findings demonstrated what causes some lung cancer patients to have an intrinsic resistance to the drug osimertinib.
Read MorePosted by Chaunie Brusie | Apr 6, 2019 | Research |
Individuals identified with VeriStrat poor results had significantly lower overall survival when treated with immune checkpoint inhibitor-based regimens.
Read MorePosted by Chaunie Brusie | Mar 27, 2019 | Breast |
The assay is the first companion diagnostic approved for identifying triple-negative breast cancer patients who are eligible for PD-L1 immunotherapy.
Read MorePosted by Steve Halasey | Mar 25, 2019 | Cardiovascular, Research, Respiratory Disease |
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read More